# Prevention of Cisplatin-induced Nephrotoxicity

> **NCT06196853** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Mahidol University** · enrollment: 24 (estimated)

## Conditions studied

- Acute Kidney Injury
- Renal Tubulopathy

## Interventions

- **DRUG:** Aminophylline

## Key facts

- **NCT ID:** NCT06196853
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06196853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06196853, "Prevention of Cisplatin-induced Nephrotoxicity". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06196853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*